The Mesothelioma Research Foundation of America has a mission: fund research that will lead to the quickest cure for mesothelioma. Mesothelioma, a cancer of the lining of the lungs caused by asbestos exposure, has very few treatment options at this time. Since the year 2001, the foundation has funded the opening of the Mesothelioma Laboratory under the supervision of Dr. Gill at the USC/Norris Comprehensive Cancer Center in Los Angeles. In the process, Dr. Gill (a board certified oncologist and hematologist) had received FDA approval from the U.S. Government to do Phase I Clinical Trials on a new mesothelioma treatment drug called Veglin, whose research was 100% funded by the foundation. It proved successful in Phase I and Phase II of the clinical trials for Veglin began July 30th, 2004. We are all very excited at the possibilities of a more effective treatment over what presently is available for mesothelioma victims.